Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,6412,660 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Overcoming resistance to KRAS inhibitors through a fragment-based chemoproteomics approach
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2025

Abstract A major breakthrough in recent years has been the development of selective inhibitors that target KRASG12C mutations found in lung, colon, and other rare cancer typ. Both...

$4.33M
USD
Active NON-SBIR/STTR RPGS
The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

Project Summary/Abstract Cervical cancer disproportionately affects women of color from low-socioeconomic geographical locations. Locations, such as sub-Saharan Africa, can also ha...

$6.66M
USD
Completed SBIR-STTR RPGS
Process Development and Preclinical Advancement of a Novel Nanoparticle Formulation for Immune Activation
NATIONAL CANCER INSTITUTE Saros Therapeutics Inc United States 2023 – 2025

Summary Despite the success of immune checkpoint inhibitors for some types of cancer, the overall response rate remains suboptimal. The majority of solid tumors exclude T-cells (te...

$11.97M
USD
Active RESEARCH CENTERS
Bioinformatics and Biostatistics Core
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

Core B: Bioinformatics and Biostatistics Core SUMMARY/ABSTRACT The primary goal of the Bioinformatics and Biostatistics Core is to provide centralized biostatistics, bioinformatics...

Active NON-SBIR/STTR RPGS
The role of the cohesin complex in hematopoietic transformation and leukemia maintenance
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

PROJECT SUMMARY In this proposal, we will define the effects of epigenetic dysregulation via Stag2 loss on three-dimensional chromatin structure and transcriptional regulation. We...

$1.19M
USD
Active NON-SBIR/STTR RPGS
The effectiveness, cost-effectiveness, and budget impact of interventions to improve the delivery of cervical cancer screening in Puerto Rico.
NATIONAL CANCER INSTITUTE Comprehensive Cancer Center/ Univ/Pr United States 2023 – 2028

PROJECT SUMMARY Cervical cancer incidence is increasing dramatically (2.5% per year) in Puerto Rico (PR), with increased occurrence of regional (1.7% per year) and distant (4.7% pe...

$505.9K
USD
Active RESEARCH CENTERS
A digital twin to track and predict the evolution of pediatric neuroblastoma tumors
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

SUMMARY/ABSTRACT This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA-24-015. The proposed project aims to pioneer the deve...

$2.5M
USD
Active NON-SBIR/STTR RPGS
Regulation of extracellular proteases in prostate cancer progression to a metastatic phenotype
NATIONAL CANCER INSTITUTE University of Nebraska Medical Center United States 2023 – 2028

No changes from the Parent (CA275846)

$1.38M
USD
Active NON-SBIR/STTR RPGS
Examining the effect of biological sex on the tumor microenvironment and immunotherapy response
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2023 – 2028

Project Summary The parent grant focuses on the genetic determinants of distinct immune microenvironments and response to immunotherapy. The objective focuses on determining the ge...

$423.6K
USD
Active RESEARCH CENTERS
Studying the evolution of drug resistance in prostate cancer at the single cell level
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

PROJECT SUMMARY Patients with aggressive cancers often present with no pharmacologically actionable mutations and poor or no sensitivity to immune checkpoint blockade, thus derivin...

$1.65M
USD
Active RESEARCH CENTERS
The SIK2 Inhibitor GRN-300 Enhances PARP Inhibitor Sensitivity and Cytotoxic T-Cell Function in Ovarian Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

Ovarian cancer is a significant cause of morbidity and mortality that affects nearly 300,000 women worldwide each year. Its poor outcomes relate to delayed diagnosis and developmen...

Active RESEARCH CENTERS
Drug Mechanism of Action-based targeting of tumor subpopulations
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

Patients with aggressive cancers often present with no pharmacologically actionable mutations and fail to respond to immune checkpoint blockade, thus deriving only modest improveme...

Active RESEARCH CENTERS
Outreach Core
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

Project Summary Crucial to the long-lasting impact of the Center for Cancer Systems Therapeutics (CaST) is a robust and inclusive Outreach effort. The community and computational i...

Completed NON-SBIR/STTR RPGS
Implementation of a qPCR-based assay for the quantification of SARS-CoV-2-specific T cells in immunocompromised patients
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2023 – 2024

SUMMARY Long-term protection from viral infections is mediated by both the humoral and cellular immune pathways. Multiple Myeloma (MM) is the second most common hematological malig...

$2.8M
USD
Completed OTHER RESEARCH-RELATED
Cancer Center Survivorship Research Forum
NATIONAL CANCER INSTITUTE University of Minnesota United States 2023 – 2024

ABSTRACT The goal of this proposed biennial survivorship symposium series is to improve cancer outcomes by creating a regular forum for researchers, clinicians, and survivors to sh...

$125K
USD
Active NON-SBIR/STTR RPGS
Increasing access to cancer trials in Minnesota (InACT-MN)
NATIONAL CANCER INSTITUTE University of Minnesota United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT In collaboration with the Masonic Cancer Center of the University of Minnesota, Britt Erickson, MD, has developed a research strategy that will leverage he...

$1.83M
USD
Completed OTHER RESEARCH-RELATED
Developing a culturally tailored mHealth symptom monitoring intervention to improve adherence to endocrine therapy among Black women with breast cancer
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2024

PROJECT SUMMARY Candidate Goals. My career goal is to reduce breast cancer health disparities in outcomes by addressing cancer care delivery issues in minority cancer populations....

$2.85M
USD
Active NON-SBIR/STTR RPGS
Targeting the mutant promoter of Telomerase Reverse Transcriptase (TERT)
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2023 – 2027

PROJECT SUMMARY TElomerase Reverse Transcriptase (TERT) is rate limiting in maintenance of telomere length by telomerase and also has telomere independent functions such as regulat...

$7.72M
USD
Active NON-SBIR/STTR RPGS
Neoadjuvant immunoradiotherapy for HPV mediated oropharynx cancer
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2023 – 2028

Project Summary HPV mediated oropharynx cancer (HPVOPC) is projected to increase in incidence in the United States over the next 20-years. Attempts to de-escalate nonsurgical treat...

$6.45M
USD
Active NON-SBIR/STTR RPGS
Targeting the mutant promoter of Telomerase Reverse Transcriptase (TERT)
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2023 – 2027

PROJECT SUMMARY TElomerase Reverse Transcriptase (TERT) is rate limiting in maintenance of telomere length by telomerase and also has telomere independent functions such as regulat...

$5.64M
USD